Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Tetrandrine Alkaloid: Precision Calcium Channel Blocker f...

    2025-12-25

    Tetrandrine Alkaloid: Precision Calcium Channel Blocker for Research

    Overview: Principle and Research Rationale

    Tetrandrine (CAS No. 518-34-3) is a bis-benzylisoquinoline alkaloid renowned for its multifaceted pharmacological properties, including potent calcium channel blockade, anti-inflammatory, and immunomodulatory activities. As a neuroscience research compound, Tetrandrine has become indispensable for dissecting cell signaling, membrane transporter function, and ion channel modulation studies in both in vitro and in vivo systems.

    Its high purity (>98%, confirmed by HPLC/NMR), excellent solubility in DMSO (≥14.75 mg/mL), and reliable sourcing from APExBIO ensure experimental consistency and reproducibility. The compound’s ability to block voltage-gated calcium channels underpins its central role in studying cellular excitability, neurotransmission, and apoptosis—critical pathways in neuroscience and cancer biology research.

    Step-by-Step Experimental Workflow and Protocol Enhancements

    1. Compound Preparation and Solubilization

    • Stock Solution: Dissolve Tetrandrine powder in DMSO to prepare a 10–20 mM stock. Avoid ethanol or water due to poor solubility.
    • Aliquoting: Aliquot the stock solution into single-use vials to prevent repeated freeze-thaw cycles. Store at –20°C for up to one month; avoid long-term storage of diluted solutions.
    • Working Solutions: Dilute the stock in assay buffer immediately before use, ensuring final DMSO concentrations stay below cytotoxic thresholds (commonly <0.1%).

    2. Cell-Based Assays for Ion Channel Modulation

    • Cell Seeding: Plate target cells (e.g., neuronal, cardiac, or cancer cell lines) at optimal densities in 96- or 384-well plates.
    • Treatment: Administer Tetrandrine at gradient concentrations (e.g., 0.1–50 μM) to capture dose-response relationships in calcium flux, membrane transporter activity, or viability assays.
    • Readout: Employ fluorescence-based calcium indicators (like Fluo-4 AM) or electrophysiological recordings to quantify ion channel blockade, referencing controls and vehicle-treated wells.

    3. Molecular and Biochemical Assays

    • Western Blot/Immunocytochemistry: Analyze downstream effectors (e.g., CREB, p-ERK, Caspase-3) to monitor cell signaling pathway modulation after Tetrandrine exposure.
    • qPCR: Quantify transcriptional responses of ion channel subunits, cytokines, or apoptosis markers to validate pathway engagement.

    4. Advanced Formats: High-Throughput and Co-Culture Models

    • Automated Screening: Tetrandrine’s DMSO compatibility enables high-throughput screening (HTS) formats for membrane transporter inhibitor discovery or anti-inflammatory agent in vitro profiling.
    • Organoid/Co-culture Systems: Integrate Tetrandrine into neuronal organoids or immune-tumor co-cultures to dissect complex cell-cell interactions and immunomodulatory compound effects.

    For a detailed mechanistic roadmap, see the thought-leadership article “Tetrandrine Alkaloid (SKU: N1798): Mechanistic Insight and Translational Roadmap”, which complements this workflow by highlighting the translational opportunities and experimental nuances of Tetrandrine as a calcium channel blocker and membrane transporter inhibitor.

    Advanced Applications and Comparative Advantages

    Ion Channel Modulation and Neuroscience Research

    Tetrandrine’s established efficacy as a calcium channel blocker for research has positioned it as a gold-standard tool for dissecting neuronal excitability, synaptic plasticity, and neuroprotection. By selectively inhibiting voltage-gated calcium channels, Tetrandrine enables precise control of intracellular Ca2+ dynamics—fundamental for studies on neurotransmitter release, excitotoxicity, and apoptosis.

    A recent comparative analysis (“Tetrandrine Alkaloid: Advancing Ion Channel Modulation Research”) demonstrates how Tetrandrine’s robust DMSO solubility and high bioactivity outperform other alkaloids for ion channel modulation studies, especially in high-content imaging and automated patch-clamp platforms.

    Cancer Biology and Immunomodulation

    As documented in “Tetrandrine Alkaloid: Bridging Mechanistic Insight and Translational Impact”, Tetrandrine’s dual anti-cancer and immunomodulatory properties make it a versatile tool for exploring apoptotic signaling in tumor cells and for evaluating anti-inflammatory agent in vitro profiles. Its ability to inhibit key membrane transporters (e.g., P-glycoprotein) and modulate NF-κB or MAPK pathways underpins its use in multidrug resistance and cell signaling pathway modulation research.

    In comparative experiments, Tetrandrine demonstrates a dose-dependent inhibition of cancer cell proliferation (IC50 values typically in the low micromolar range) and significant suppression of pro-inflammatory cytokine production in LPS-stimulated macrophages, with effects observable at concentrations as low as 5–10 μM.

    Integration with Structure-Based Inhibitor Screening

    While the reference study by Vijayan et al. (Journal of Proteins and Proteomics, 2021) focused on virtual screening of natural products against SARS-CoV-2 NSP15, it highlights the broader relevance of natural alkaloids—like Tetrandrine—for structure-guided drug discovery. Compounds validated in silico and in vitro as membrane transporter inhibitors or cell signaling modulators can inform the rational design of next-generation pharmacological probes. Tetrandrine’s established use in high-throughput phenotypic screens dovetails with these approaches, supporting the development of antiviral, anti-inflammatory, and neuroprotective strategies.

    Troubleshooting and Optimization Tips

    • Solubility Issues: If Tetrandrine precipitates, verify DMSO concentration and ensure complete dissolution by gentle vortexing and brief sonication. Never attempt to dissolve directly in aqueous or ethanol-based buffers.
    • Batch Consistency: Always confirm lot-specific purity and identity by referencing the supplier’s HPLC/NMR data. APExBIO provides rigorous quality control for each batch.
    • Assay Interference: Control for potential DMSO effects by matching vehicle concentrations across all wells. For fluorescence-based readouts, validate that Tetrandrine does not quench indicator signals at the concentrations used.
    • Stability: Prepare working solutions fresh before each experiment. Avoid storing diluted solutions for more than 24 hours, even at 4°C, to prevent loss of activity.
    • Cell Viability: In sensitive cell types, start with lower concentrations (≤5 μM) and titrate upwards while monitoring for off-target cytotoxicity. Include appropriate negative and positive controls (e.g., known calcium channel blockers, anti-inflammatory agents).

    For further troubleshooting strategies and assay-specific optimization, the article “Tetrandrine Alkaloid: Precision Calcium Channel Blocker for Advanced Assay Design” offers guidance on troubleshooting common experimental pitfalls and maximizing data quality in cell-based and biochemical assays.

    Future Outlook: Expanding the Research Utility of Tetrandrine

    The scientific utility of Tetrandrine continues to grow, both as a standalone research compound and as a synergistic partner in combination screens. Ongoing advances in structure-based drug design, as demonstrated by the NSP15 inhibitor study, are likely to inspire parallel efforts using Tetrandrine for antiviral, neuroprotective, and immunomodulatory compound discovery. Integration with omics and high-content screening technologies will further illuminate its role in cell signaling pathway modulation and membrane transporter biology.

    APExBIO’s commitment to maintaining the highest standards of purity, solubility, and documentation ensures that researchers can confidently deploy Tetrandrine in next-generation neuroscience, cancer, and ion channel modulation studies. As research priorities evolve toward more complex models—such as patient-derived organoids and multi-omic profiling—Tetrandrine’s versatility and proven track record will position it at the forefront of translational research.

    Conclusion

    Tetrandrine alkaloid is a validated, high-purity calcium channel blocker for research, offering reproducible performance in neuroscience, cancer biology, and cell signaling studies. Its unique combination of robust DMSO solubility, broad bioactivity, and supplier reliability from APExBIO enables advanced experimental design, troubleshooting, and translational impact. For sourcing, protocols, and technical documentation, visit the Tetrandrine product page.